LINC01177

Across TCGA pan-cancer cohorts, LINC01177 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01177 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC01177 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01177 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

UCS, LIHC, and BLCA are the cancer types where LINC01177 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.104	0.688	<.001	108	view →
LIHC	DFS	Tertile	All	0.092	0.546	<.001	90	view →
BLCA	DFS	Tertile	III,IV	0.182	0.553	<.001	66	view →
OV	DFS	Tertile	II,III,IV	0.445	0.354	.018	58	view →
PAAD	DFS	Tertile	All	0.006	0.505	<.001	45	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
LUAD	OS	Tertile	All	0.293	0.703	<.001	36	view →
READ	DFS	Tertile	All	0.170	0.742	<.001	36	view →
SKCM	DFS	Tertile	IV	0.026	0.477	<.001	27	view →
THCA	OS	Tertile	III,IV	0.179	0.810	<.001	27	view →
LUSC	OS	Tertile	II,III,IV	0.173	0.677	.029	9	view →
SARC	DFS	Tertile	All	0.178	0.594	.034	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC01177–UCS (OS)

Open the UCS breakdown →